Liberty Health Sciences (LHSIF) Stock Price, News & Analysis

Company Overview

Liberty Health Sciences (OTCMKTS: LHSIF) is a vertically integrated medical cannabis company headquartered in Miami, Florida. Founded in 2015, the firm focuses on the cultivation, processing, and distribution of cannabis-based products for patients throughout the state. Leveraging modern greenhouse technology and standardized cultivation protocols, Liberty Health Sciences produces consistent, high-quality flower and biomass that meet rigorous safety and potency standards.

The company’s product portfolio encompasses a range of medical cannabis formulations, including dried flower, vape cartridges, tinctures, capsules, and transdermal topicals. Liberty Health Sciences operates multiple cultivation sites and manufacturing facilities designed to scale production and maintain stringent quality control. Through its in-house research and development team, the company continually explores new delivery methods and product formulations tailored to specific patient needs.

As a Florida-licensed operator, Liberty Health Sciences serves a rapidly expanding medical cannabis market that caters to patients with qualifying conditions such as chronic pain, epilepsy, and post-traumatic stress disorder. The company has established a network of dispensaries across key Florida regions, ensuring patient access to its branded products. In addition, Liberty Health Sciences is actively pursuing opportunities to expand into other regulated markets in the United States as state-level legislation evolves.

Liberty Health Sciences is led by a management team with deep experience in consumer goods, pharmaceutical manufacturing, and regulated industries. Chief Executive Officer Harley Gelbard, a founding member of the company, brings extensive leadership in healthcare operations and product development. The company’s board and senior executives draw on backgrounds in finance, regulatory compliance, and agricultural technology to guide strategic growth and maintain industry-leading standards.

Key Stats

• Today's Range: $1.10 to $1.17
• 50-Day Range: $1.14 to $1.14
• 52-Week Range: $0.23 to $1.23
• Volume: 671,400 shs
• Average Volume: 1.67 million shs
• Market Capitalization: $392.01 million
• P/E Ratio: 38.17
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LHSIF Stock Analysis - Frequently Asked Questions

How have LHSIF shares performed this year?

Liberty Health Sciences' stock was trading at $1.1446 at the beginning of 2025. Since then, LHSIF shares have increased by 0.0% and is now trading at $1.1446.

How do I buy shares of Liberty Health Sciences?

Shares of LHSIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:LHSIF
• CIK: N/A
• Web: www.libertyhealthsciences.com
• Phone: 833-254-4877
• Fax: N/A
• Employees: 291
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 38.17
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $16.80 million
• Net Margins: 19.34%
• Pretax Margin: N/A
• Return on Equity: 9.51%
• Return on Assets: 6.78%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.93
• Quick Ratio: 0.72

Sales & Book Value

• Annual Sales: $37.77 million
• Price / Sales: 10.38
• Cash Flow: $0.04 per share
• Price / Cash Flow: 26.78
• Book Value: $0.31 per share
• Price / Book: 3.69

Miscellaneous

• Outstanding Shares: 342,490,000
• Free Float: N/A
• Market Cap: $392.01 million
• Optionable: Not Optionable
• Beta: 1.70